Figure 3 : Percentage reduction in symptom-medication score, total symptom score, and medication score.

From: Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial

Figure 3

(a) Japanese cedar/cypress pollen season (entire pollen season). (b) Japanese cedar pollen (JCP) season. Open squares: active group (n = 26); solid square: placebo group (n = 28). Data are least square (LS) mean weekly score ± SEs during entire pollen or JCP season. *p < 0.05, between active and placebo groups. Statistical analysis was performed using ANCOVA.